Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Sep 22, 2025, 07:45 ET Jazz Pharmaceuticals Showcases Phase 4 Data Demonstrating Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Effects and Real-World Evidence at World Sleep and Psych Congresses
the global sleep community, which informs the health complexities of people living with narcolepsy and idiopathic hypersomnia," said Kelvin Tan, MB BCh, MRCPCH, chief medical affairs officer of Jazz Pharmaceuticals. "These robust data continue to expand our understanding of sleep disorders and the challenges
More news about: Jazz Pharmaceuticals plc
Sep 16, 2025, 07:30 ET Yasir Al-Wakeel Appointed CEO of Vesalius Therapeutics and CEO-Partner of Flagship Pioneering
for breakthroughs in treatments, targets and clinical trials, today announced the appointment of Yasir Al-Wakeel, BM BCh (Doctor of Medicine and Surgery), as CEO-Partner of Flagship and CEO of Vesalius. He succeeds John Mendlein, Executive
More news about: Flagship Pioneering